Evolutionary role of chemotherapy in advanced nasopharyngeal carcinoma: a literature-based network meta-analysis

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• WeiKRZhengRSZhangSWLiangZHLiZMChenWQNaso-pharyngeal carcinoma incidence and mortality in China, 2013Chin J Cancer20173619029122009
   PubMedGoogle Scholar
• Al-SarrafMLeblancMGiriPGChemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099J Clin Oncol1998164131013179552031
   PubMed Web of Science ®Google Scholar
• ChenYSunYLiangSBProgress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemo-radiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of ChinaCancer2013119122230223823576020
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChuaDTRandomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst2010102151188119820634482
   PubMed Web of Science ®Google Scholar
• WeeJTanEHTaiBCRandomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJ Clin Oncol200523276730673816170180
   PubMed Web of Science ®Google Scholar
• ChenLHuCSChenXZAdjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialEur J Cancer20177515015828235726
   PubMed Web of Science ®Google Scholar
• YiJLGaoLHuangXDNasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institutionInt J Radiat Oncol Biol Phys200665116116816542792
   PubMed Web of Science ®Google Scholar
• CaoSMYangQGuoLNeoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase III multicentre randomised controlled trialEur J Cancer201775142328214653
   PubMed Web of Science ®Google Scholar
• SunYLiWFChenNYInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialLancet Oncol201617111509152027686945
   PubMed Web of Science ®Google Scholar
• FrikhaMAuperinATaoYA randomized trial of induction docetaxelcisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)Ann Oncol201829373173629236943
   PubMed Web of Science ®Google Scholar
• HuiEPMaBBLeungSFRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaJ Clin Oncol200927224224919064973
   PubMed Web of Science ®Google Scholar
• HongRLHsiaoCFTingLLFinal results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 StudyAnn Oncol20182991972197930016391
   PubMed Web of Science ®Google Scholar
• Ribassin-MajedLMarguetSLeeAWMWhat is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysisJ Clin Oncol201735549850527918720
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• ChenYPTangLLYangQInduction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trialsClin Cancer Res20182481824183329431618
   PubMed Web of Science ®Google Scholar
• RückerGSchwarzerGRanking treatments in frequentist network meta-analysis works without resampling methodsBMC Med Res Methodol2015155826227148
   PubMed Web of Science ®Google Scholar
• RückerGNetwork meta-analysis, electrical networks and graph theoryRes Synth Methods20123431232426053424
   PubMed Web of Science ®Google Scholar
• ChaimaniAHigginsJPMavridisDSpyridonosPSalantiGGraphical tools for network meta-analysis in STATAPLoS One2013810e7665424098547
   PubMed Web of Science ®Google Scholar
• SalantiGAdesAEIoannidisJPGraphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJ Clin Epidemiol201164216317120688472
   PubMed Web of Science ®Google Scholar
• LinJCJanJSHsuCYLiangWMJiangRSWangWYPhase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survivalJ Clin Oncol200321463163712586799
   PubMed Web of Science ®Google Scholar
• ChenQYWenYFGuoLConcurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trialJ Natl Cancer Inst2011103231761177022056739
   PubMed Web of Science ®Google Scholar
• FountzilasGCiuleanuEBobosMInduction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationAnn Oncol201223242743521525406
   PubMed Web of Science ®Google Scholar
• LeeAWNganRKTungSYPreliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluoro-uracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaCancer201512181328133825529384
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChanATA randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinomaRadiother Oncol2011981152220971520
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChanATPreliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys200666114215116904519
   PubMed Web of Science ®Google Scholar
• ChenLHuCSChenXZConcurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialLancet Oncol201213216317122154591
   PubMed Web of Science ®Google Scholar
• ChenLHuCSChenXZAdjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialEur J Cancer20177515015828235726
   PubMed Web of Science ®Google Scholar
• ChanATLeungSFNganRKOverall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst200597753653915812080
   PubMed Web of Science ®Google Scholar
• ChanATTeoPMNganRKConcurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trialJ Clin Oncol20022082038204411956263
   PubMed Web of Science ®Google Scholar
• LeeAWLauWHTungSYPreliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupJ Clin Oncol200523286966697516192584
   PubMed Web of Science ®Google Scholar
• ChenYLiuMZLiangSBPreliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of ChinaInt J Radiat Oncol Biol Phys20087151356136418472356
   PubMed Web of Science ®Google Scholar
• ChenYSunYLiangSBProgress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemo-radiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of ChinaCancer2013119122230223823576020
   PubMed Web of Science ®Google Scholar
• WuXHuangPYPengPJLong-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinomaAnn Oncol20132482131213623661293
   PubMed Web of Science ®Google Scholar
• ZhangLZhaoCPengPJPhase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary resultsJ Clin Oncol200523338461846816230677
   PubMed Web of Science ®Google Scholar
• ChanATLeungSFNganRKOverall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst200597753653915812080
   PubMed Web of Science ®Google Scholar
• KwongDLShamJSAuGKConcurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial studyJ Clin Oncol200422132643265315226332
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChanATA randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinomaRadiother Oncol2011981152220971520
   PubMed Web of Science ®Google Scholar
• TanTLimWTFongKWConcurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys201591595296025832687
   PubMed Web of Science ®Google Scholar
• LaiSZLiWFChenLHow does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?Int J Radiat Oncol Biol Phys201180366166820643517
   PubMed Web of Science ®Google Scholar
• SunXSuSChenCLong-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicitiesRadiother Oncol2014110339840324231245
   PubMed Web of Science ®Google Scholar